[1]
|
抗磷脂综合征诊断和治疗指南[J]. 中华风湿病学杂志, 2011(6): 407-410.
|
[2]
|
Tektonidou, M.G., Andreoli, L., Limper, M., Amoura, Z., Cervera, R., Costedoat-Chalumeau, N., Cuadrado, M.J., Dörner, T., Ferrer-Oliveras, R., Hambly, K., Khamashta, M.A., King, J., Marchiori, F., Meroni, P.L., Mosca, M., Pengo, V., Raio, L., Ruiz-Irastorza, G., Shoenfeld, Y., Stojanovich, L., Svenungsson, E., Wahl, D., Tincani, A. and Ward, M.M. (2019) EULAR Recommenda-tions for the Management of Antiphospholipid Syndrome in Adults. Annals of the Rheumatic Diseases, 78, 1296-1304. https://doi.org/10.1136/annrheumdis-2019-215213
|
[3]
|
Garcia, D. and Erkan, D. (2018) Diagnosis and Manage-ment of the Antiphospholipid Syndrome. The New England Journal of Medicine, 378, 2010-2021. https://doi.org/10.1056/NEJMra1705454
|
[4]
|
Pires, D., Rosa, G., Bettencourt, P., Rodríguez-Pintó, I., Cervera, R. and Espinosa, G. (2020) “Non-Criteria” Antiphospholipid Syndrome: A Nomenclature Proposal. Autoimmunity Reviews, 19, Article ID: 102689.
https://doi.org/10.1016/j.autrev.2020.102689
|
[5]
|
Xourgia, E. and Tektonidou, M.G. (2022) An Update on An-tiphospholipid Syndrome. Current Rheumatology Reports, 23, Article No. 84. https://doi.org/10.1007/s11926-021-01051-5
|
[6]
|
Ambati, A., Knight, J.S. and Zuo, Y. (2023) Antiphospholipid Syndrome Management: A 2023 Update and Practical Algorithm-Based Approach. Current Opinion in Rheumatology, 35, 149-160.
https://doi.org/10.1097/BOR.0000000000000932
|
[7]
|
Walter, I.J., Klein Haneveld, M.J., Lely, A.T., Bloemen-kamp, K.W.M., Limper, M. and Kooiman, J. (2021) Pregnancy Outcome Predictors in Antiphospholipid Syndrome: A Systematic Review and Meta-Analysis. Autoimmunity Reviews, 20, Article ID: 102901. https://doi.org/10.1016/j.autrev.2021.102901
|
[8]
|
Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., Derksen, R.H., De Groot, P.G., Koike, T., Meroni, P.L., Reber, G., Shoenfeld, Y., Tincani, A., Vla-choyiannopoulos, P.G. and Krilis, S.A. (2006) International Consensus Statement on an Update of the Classification Cri-teria for Definite Antiphospholipid Syndrome (APS). Journal of Thrombosis and Haemostasis, 4, 295-306. https://doi.org/10.1111/j.1538-7836.2006.01753.x
|
[9]
|
孙笑丛, 马红玲, 赵娟. 凝血功能指标及抗磷脂抗体检测在妊娠合并抗磷脂综合征患者诊断中的价值[J]. 中国妇幼保健, 2019, 34(21): 4877-4880.
|
[10]
|
Li, X., Deng, X., Duan, H., et al. (2021) Clinical Features Associated with Pregnancy Outcomes in Women with Positive Antiphospholip-id Antibodies and Previous Adverse Pregnancy Outcomes: A Real-World Prospective Study. Clinical Rheumatology, 40, 193-204. https://doi.org/10.1007/s10067-020-05203-3
|
[11]
|
Brandt, K.J., Fickentscher, C., Boehlen, F., Kruithof, E.K. and De Moerloose, P. (2014) NF-κB Is Activated from Endosomalcompartments in Antiphospholipid Antibod-ies-Treated Human Monocytes. Journal of Thrombosis and Haemostasis, 12, 779-791. https://doi.org/10.1111/jth.12536
|
[12]
|
Sciascia, S., Amigo, M.C., Roccatello, D. and Khamashta, M. (2017) Diag-nosing Antiphospholipid Syndrome: “Extra-Criteria” Manifestations and Technical Advances. Nature Reviews Rheuma-tology, 13, 548-560.
https://doi.org/10.1038/nrrheum.2017.124
|
[13]
|
Laurent, C., Ricard, L., Nguyen, Y., Boffa, J.J., Rondeau, E., Gerotziafas, G., Elalamy, I., Deriaz, S., De Moreuil, C., Planche, V., Johanet, C., Millot, F., Fain, O. and Mekinian, A. (2023) Triple Positive Profile in Antiphospholipid Syndrome: Prognosis, Relapse and Management from a Retrospective Multicentre Study. RMD Open, 9, e002534.
https://doi.org/10.1136/rmdopen-2022-002534
|
[14]
|
Simchen, M.J., Dulitzki, M., Rofe, G., Shani, H., Langevitz, P., Schiff, E. and Pauzner, R. (2011) High Positive Antibody Titers and Adverse Pregnancy Outcome in Women with An-tiphospholipid Syndrome. Acta Obstetricia et Gynecologica Scandinavica, 90, 1428-1433. https://doi.org/10.1111/j.1600-0412.2011.01236.x
|
[15]
|
郑晓娟, 邓晓莉, 刘湘源. 54例抗磷脂综合征患者的妊娠结局[J]. 北京大学学报(医学版), 2014, 46(2): 323-328.
|
[16]
|
Tao, J.J., Adurty, S., D’Angelo, D. and De Sancho, M.T. (2023) Management and Outcomes of Women with Antiphospholipid Syndrome during Pregnancy. Journal of Thrombosis and Thrombolysis, 55, 751-759.
https://doi.org/10.1007/s11239-023-02789-8
|
[17]
|
Rai, R., Cohen, H., Dave, M. and Regan, L. (1997) Randomised Controlled Trial of Aspirin and Aspirin plus Heparin in Pregnant Women with Recurrent Miscarriage Associated with Phospholipid Antibodies (or Antiphospholipid Antibodies). BMJ, 314, 253-257. https://doi.org/10.1136/bmj.314.7076.253
|
[18]
|
Empson, M., Lassere, M., Craig, J. and Scott, J. (2005) Prevention of Recurrent Miscarriage for Women with Antiphospholipid Antibody or Lupus Anticoagulant. Cochrane Database of Systematic Reviews, 2005, CD002859.
https://doi.org/10.1002/14651858.CD002859.pub2
|
[19]
|
Mak, A., Cheung, M.W., Cheak, A.A. and Ho, R.C. (2010) Combination of Heparin and Aspirin Is Superior to Aspirin Alone in Enhancing Live Births in Patients with Re-current Pregnancy Loss and Positive Anti-Phospholipid Antibodies: A Meta-Analysis of Randomized Controlled Trials and Meta-Regression. Rheumatology (Oxford), 49, 281-288.
https://doi.org/10.1093/rheumatology/kep373
|
[20]
|
Cervera, R., Piette, J.C., Font, J., Khamashta, M.A., Shoenfeld, Y., Camps, M.T., Jacobsen, S., Lakos, G., Tincani, A., Kontopoulou-Griva, I., Galeazzi, M., Meroni, P.L., Derksen, R.H., De Groot, P.G., Gromnica-Ihle, E., Baleva, M., Mosca, M., Bombardieri, S., Houssiau, F., Gris, J.C., Quéré, I., Hachulla, E., Vasconcelos, C., Roch, B., Fernández-Nebro, A., Boffa, M.C., Hughes, G.R., Ingelmo, M. and Eu-ro-Phospholipid Project Group (2002) Antiphospholipid Syndrome: Clinical and Immunologic Manifestations and Pat-terns of Disease Expression in a Cohort of 1,000 Patients. Arthritis & Rheumatology, 46, 1019-1027. https://doi.org/10.1002/art.10187
|
[21]
|
Rodger, M.A., Carrier, M., Le Gal, G., Martinelli, I., Perna, A., Rey, E., De Vries, J.I. and Gris, J.C. (2014) Meta-Analysis of Low-Molecular-Weight Heparin to Prevent Recurrent Placen-ta-Mediated Pregnancy Complications. Blood, 123, 822-828. https://doi.org/10.1182/blood-2013-01-478958
|
[22]
|
Committee on Practice Bulletins—Obstetrics, American Col-lege of Obstetricians and Gynecologists (2012) Practice Bulletin No. 132: Antiphospholipid Syndrome. Obstetrics & Gynecology, 120, 1514-1521.
https://doi.org/10.1097/01.AOG.0000423816.39542.0f
|
[23]
|
Urban, M.L., Bettiol, A., Mattioli, I., Emmi, G., Di Scala, G., Avagliano, L., Lombardi, N., Crescioli, G., Virgili, G., Serena, C., Mecacci, F., Ravaldi, C., Vannacci, A., Sil-vestri, E. and Prisco, D. (2021) Comparison of Treatments for the Prevention of Fetal Growth Restriction in Obstetric Antiphospholipid Syndrome: A Systematic Review and Network Meta-Analysis. Internal and Emergency Medicine, 16, 1357-1367. https://doi.org/10.1007/s11739-020-02609-4
|
[24]
|
Fredi, M., Andreoli, L., Aggogeri, E., Bettiga, E., Lazzaroni, M.G., Le Guern, V., Lojacono, A., Morel, N., Piette, J.C., Zatti, S., Costedoat-Chalumeau, N. and Tincani, A. (2018) Risk Factors for Adverse Maternal and Fetal Outcomes in Women with Confirmed APL Positivity: Results from a Multicenter Study of 283 Pregnancies. Frontiers in Immunology, 9, Article No. 864. https://doi.org/10.3389/fimmu.2018.00864
|
[25]
|
吴庆军, 朱燕林, 唐福林. 抗磷脂综合征100例临床特征分析[J]. 中华风湿病学杂志, 2007, 11(11): 675-678.
|
[26]
|
Rai, R.S., Regan, L., Clifford, K., Pickering, W., Dave, M., Mackie, I., McNally, T. and Cohen, H. (1995) Antiphospholipid Antibodies and Beta 2-Glycoprotein-I in 500 Women with Recurrent Miscarriage: Results of a Comprehensive Screening Approach. Human Reproduction, 10, 2001-2005.
https://doi.org/10.1093/oxfordjournals.humrep.a136224
|
[27]
|
Alijotas-Reig, J., Esteve-Valverde, E., Ferrer-Oliveras, R., LLurba, E., Ruffatti, A., Tincani, A., Lefkou, E., Bertero, M.T., Espinosa, G., De Carolis, S., Rovere-Querini, P., Lundelin, K., Picardo, E., Mekinian, A. and EUROAPS Study Group (2018) Comparative Study between Obstetric An-tiphospholipid Syndrome and Obstetric Morbidity Related with Antiphospholipid Antibodies. Medicina Clínica (Barc), 151, 215-222. https://doi.org/10.1016/j.medcli.2017.11.017
|
[28]
|
Mayer-Pickel, K., Tabacco, S., Arnau, A., TrapÉ, J., Ruiz-Hidalgo, D., Sos, L., Farran-Codina, I. and EUROAPS Study Group (2020) Comparative Study of Obstetric Antiphospholipid Syndrome (OAPS) and Non-Criteria Obstetric APS (NC-OAPS): Report of 1640 Cases from the EUROAPS Registry. Rheumatology (Oxford), 59, 1306-1314.
https://doi.org/10.1093/rheumatology/kez419
|
[29]
|
陈玥, 王敬民, 李相君, 李晓东, 龙尚琴, 杨晓杰. 小剂量阿司匹林联合低分子肝素治疗时长对产科抗磷脂综合征妊娠结局的影响[J]. 中国实用妇科与产科杂志, 2022, 38(7): 739-742. https://doi.org/10.19538/J.Fk2022070115
|